Bordetella Pertussis Toxin vs Nivolumab

## Bordetella Pertussis Toxin vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Bordetella Pertussis Toxin** and **Nivolumab**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Bordetella Pertussis Toxin — N/A; Nivolumab — 27 days.

## Chemical Properties

**Type**: Bordetella Pertussis Toxin — Vaccine component; Nivolumab — Antibody.